Daré Bioscience, Inc.

DARE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Oct 6, 2026 DEF 14A
8-K Oct 2, 2026 8-K
8-K Oct 1, 2026 8-K
PRE 14A Sep 23, 2026 PRE 14A
8-K Sep 11, 2026 8-K
8-K Sep 9, 2026 8-K
424B3 Sep 4, 2026 424B3
EFFECT Sep 3, 2026
SCHEDULE 13G Aug 28, 2026
S-1 Aug 26, 2026 S-1
SCHEDULE 13G Aug 24, 2026
D Aug 20, 2026
253G2 Aug 19, 2026 253G2
8-K Aug 17, 2026 8-K
424B5 Aug 17, 2026 424B5
8-K Aug 13, 2026 8-K
10-Q Aug 13, 2026 10-Q
8-K Jul 24, 2026 8-K
253G2 Jul 17, 2026 253G2
8-K Jul 17, 2026 8-K
8-K Jul 13, 2026 8-K
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
← Newer Page 1 of 32 · 776 filings Older →